Cooper Consumer Health announces the signing of an exclusive negotiation agreement to take over Laboratoire Tradiphar.

2020 November | PRESS RELEASE

Cooper Consumer Health has signed an exclusive negotiation agreement to acquire 100% of the shares of Laboratoire Tradiphar, a French-based laboratory that notably manufactures and distributes the M.O.Cochon ointment, an iconic brand with a strong heritage in France.

With this acquisition, Cooper Consumer Health expands its offering in the Foot care, Oral care and Gastro care categories and appends a large range of OTC drugs, medical devices, cosmetics and food supplements to its portfolio.

This acquisition participates into the strategy of Cooper Consumer Health to reinforce its position as one of the few European leaders in the self-care and medication businesses through a portfolio of high profile brands in all major categories.

“We are thrilled to welcome Tradiphar to the Group. The company has developed a large range of well- known self-care brands that are complementary to our current portfolio. We are now looking forward to bringing Tradiphar to the next level!” said Bauke Rouwers, CEO of Cooper Consumer Health.